Labocanna Sa Zy 10 Stock Cash And Equivalents
| 9Y2 Stock | EUR 0.06 0 2.16% |
LABOCANNA SA ZY 10 fundamentals help investors to digest information that contributes to LABOCANNA's financial success or failures. It also enables traders to predict the movement of LABOCANNA Stock. The fundamental analysis module provides a way to measure LABOCANNA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LABOCANNA stock.
LABOCANNA |
LABOCANNA SA ZY 10 Company Cash And Equivalents Analysis
LABOCANNA's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, LABOCANNA SA ZY 10 has 0.0 in Cash And Equivalents. This is 100.0% lower than that of the Industrials sector and about the same as Specialty Business Services (which currently averages 0.0) industry. The cash and equivalents for all Germany stocks is 100.0% higher than that of the company.
LABOCANNA Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LABOCANNA's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LABOCANNA could also be used in its relative valuation, which is a method of valuing LABOCANNA by comparing valuation metrics of similar companies.LABOCANNA is currently under evaluation in cash and equivalents category among its peers.
LABOCANNA Fundamentals
| Return On Equity | 82.13 | |||
| Return On Asset | 6.13 | |||
| Profit Margin | 119.42 % | |||
| Current Valuation | 5.16 M | |||
| Shares Outstanding | 7.65 M | |||
| Gross Profit | 40 K | |||
| Current Ratio | 0.49 X | |||
| Beta | 3.1 | |||
| Market Capitalization | 4.34 M |
About LABOCANNA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LABOCANNA SA ZY 10's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LABOCANNA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LABOCANNA SA ZY 10 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in LABOCANNA Stock
LABOCANNA financial ratios help investors to determine whether LABOCANNA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LABOCANNA with respect to the benefits of owning LABOCANNA security.